From: Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer
Characteristic | Exp(B) | 95% CI for Exp(B) | P value |
---|---|---|---|
Age | 0.553 | 0.267-2.292 | 0.371 |
Tumor size | 1.978 | 1.176-4.126 | 0.003 |
Clinical stage | 3.936 | 1.774-6.882 | 0.001 |
Tumor stage | 2.217 | 0.557-7.826 | 0.072 |
Lymph node metastasis | 4.376 | 2.287-8.762 | 0.000 |
Her-2 status | 1.549 | 0.736-3.472 | 0.059 |
AGBL2 | 1.517 | 1.073-3.432 | 0.031 |